Company Filing History:
Years Active: 2015
Title: Lynne Maree Atley: Innovator in Cancer Treatment
Introduction
Lynne Maree Atley is a prominent inventor based in Williamstown, Australia. She has made significant contributions to the field of cancer research, particularly in the modulation of insulin-like growth factor I receptor expression. Her innovative work aims to provide new methods for treating and preventing cancer.
Latest Patents
Lynne Maree Atley holds one patent titled "Modulation of insulin like growth factor I receptor expression in cancer." This patent outlines methods, compounds, and compositions designed to reduce the expression of IGF-IR mRNA and protein in animals. The techniques described are intended to treat, prevent, delay, or ameliorate tumors or cancer symptoms.
Career Highlights
Atley is associated with Antisense Therapeutics Limited, where she applies her expertise in developing therapeutic solutions for cancer. Her work is pivotal in advancing the understanding and treatment of cancer through innovative approaches.
Collaborations
Lynne collaborates with notable colleagues, including George Tachas and Christopher John Wraight. Their combined efforts contribute to the advancement of cancer research and the development of effective treatments.
Conclusion
Lynne Maree Atley's contributions to cancer treatment through her innovative patent and collaboration with esteemed colleagues highlight her significant role in the field. Her work continues to inspire advancements in medical research and therapeutic development.